Log inStart free trialBook a demo
Book a demoLog inStart free trial
Media Database
>
Christina Cheddar Berk

Christina Cheddar Berk

Assistant Managing Editor at CNBC Online

Contact this person
Email address
c*****@*******.comGet email address
Influence score
70
Phone
(XXX) XXX-XXXX Get mobile number
Location
United States
Languages
  • English
Covering topics
  • Aviation
  • Business
  • Commerce
  • Health & Medicine
  • Food
  • Transportation and Logistics

View more media outlets and journalists by signing up to Prowly

View latest data and reach out all from one place
Sign up for free

Recent Articles

cnbc.com

People may eat more calories after stopping weight loss drugs, according to Deutsche Bank survey ...

Ozempic and Wegovy have been cheered for helping people shed unwanted pounds, but the findings of a recent poll underscore the challenges patients face.
11 months ago
cnbc.com

Elanco's $1.3 billion deal may give the animal health company more ...

Elanco CEO Jeff Simmons expects the company to debut six products over the next two years that will each see more than $100 million in peak sales.
10 months ago
cnbc.com

Morgan Stanley ponders if Eli Lilly could be the first $1 trillion ...

Eli Lilly’s ‘diabesity’ medications are positioning it to become the first pharmaceutical company to hit $1 trillion in market cap, Morgan Stanley said.
9 months ago
cnbc.com

Biotech stocks are ready to break out. They just need one more thin...

Biotech stocks tend to outperform in the months leading up to an interest rate cut. But other factors are driving performance too.
8 months ago
cnbc.com

Investors may be missing these commercial real estate opportunities...

Investors are avoiding bank stocks with high concentrations of commercial real estate. But they may also miss banks that have other risky loans.
5 months ago
cnbc.com

Investors want proof AI will aid drug discovery. Evidence may come ...

Nvidia is a fan of Recursion Pharmaceuticals. Data expected from the company will help determine valuations for stocks using AI to discover new drugs.
5 months ago
cnbc.com

Walmart has the advantage for back-to-school — and that's really ba...

Sticky inflation has produced savvy consumers, who are very deliberate about where they spend their money. That’s an advantage for some retailers.
4 months ago
cnbc.com

Eli Lilly reports earnings Thursday. Here's what Wall Street is wat...

Novo Nordisk saw price pressure for its GLP-1 drugs Ozempic and Wegovy. Investors want to know how Eli Lilly's Zepbound performed.
4 months ago
cnbc.com

Eli Lilly's second quarter eases Zepbound pricing fears and suggest...

"Investors were nervous going in and this print would come as a huge relief," said Mohit Bansal, an analyst at Wells Fargo.
4 months ago
cnbc.com

As consumers trade down to cheaper private label brands, these stoc...

Month after month of soaring prices has wreaked havoc on household finances.These retailers with saavy store brands stand to benefit.
3 months ago
cnbc.com

Recursion gets FDA approval to begin phase 1 trials of AI-discovere...

Recursion gets FDA approval to begin phase 1 trials of AI-discovered cancer treatment
about 2 months ago